Psychology - OPEN Foundation

Cessation and reduction in alcohol consumption and misuse after psychedelic use

Garcia-Romeu, A., Davis, A. K., Erowid, F., Erowid, E., Griffiths, R. R., & Johnson, M. W. | Journal of Psychopharmacology | 14 May 2019

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.

Mithoefer, M. C., Feduccia, A. A., Jerome, L., Mithoefer, A., Wagner, M., Walsh, Z., ... & Doblin, R. | Psychopharmacology | 7 May 2019

Effects of MDMA on attention to positive social cues and pleasantness of affective touch.

Bershad, A. K., Mayo, L. M., Van Hedger, K., McGlone, F., Walker, S. C., & de Wit, H. | Neuropsychopharmacology | 30 April 2019

Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers.

Baggott, M. J., Garrison, K. J., Coyle, J. R., Galloway, G. P., Barnes, A. J., Huestis, M. A., & Mendelson, J. E. | Journal of psychoactive drugs | 9 April 2019

Ketamine: A Paradigm Shift for Depression Research and Treatment

Krystal, J. H., Abdallah, C. G., Sanacora, G., Charney, D. S., & Duman, R. S. | Neuron | 6 March 2019

Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents

Cameron, L. P., Benson, C. J., DeFelice, B. C., Fiehn, O., & Olson, D. E. | ACS chemical neuroscience | 4 March 2019

5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety

Davis, A. K., So, S., Lancelotta, R., Barsuglia, J. P., & Griffiths, R. R.| The American journal of drug and alcohol abuse | 1 March 2019

Psychedelics and Dying Care: A Historical Look at the Relationship between Psychedelics and Palliative Care.

Dyck, E. | Journal of psychoactive drugs | 1 March 2019

Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers

Erritzoe, D., Smith, J., Fisher, P. M., Carhart-Harris, R., Frokjaer, V. G., & Knudsen, G. M.| Journal of Psychopharmacology | 28 February 2019

Effective connectivity changes in LSD-induced altered states of consciousness in humans

Preller, K. H., Razi, A., Zeidman, P., Stämpfli, P., Friston, K. J., & Vollenweider, F. X. | Proceedings of the National Academy of Sciences | 12 February 2019

The tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisis

Argento, E., Tupper, K. W., & Socias, M. E. | International Journal of Drug Policy | 7 February 2019

Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users

Ona, G., Kohek, M., Massaguer, T., Gomariz, A., Jiménez, D. F., Dos Santos, R. G., & Bouso, J. C. | Journal of psychoactive drugs | 7 February 2019

A systematic study of microdosing psychedelics

Polito, V., & Stevenson, R. J. | PloS one | 6 February 2019

Greater empathy in MDMA users

Carlyle, M., Stevens, T., Fawaz, L., Marsh, B., Kosmider, S., & Morgan, C. J. | Journal of Psychopharmacology | 5 February 2019

Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports.

Martial, C., Cassol, H., Charland-Verville, V., Pallavicini, C., Sanz, C., Zamberlan, F., ... & Tagliazucchi, E. | Consciousness and cognition | 1 February 2019

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.

Madsen, M. K., Fisher, P. M., Burmester, D., Dyssegaard, A., Stenbæk, D. S., Kristiansen, S., ... & Erritzoe, D. | Neuropsychopharmacology | 26 January 2019

Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants.

Reed, J. L., Nugent, A. C., Furey, M. L., Szczepanik, J. E., Evans, J. W., & Zarate Jr, C. A. | Biological Psychiatry: Cognitive Neuroscience and Neuroimaging | 25 January 2019

Neurochemical models of near-death experiences: A large-scalestudy based on the semantic similarity of written reports

Martial, C., Cassol, H., Charland-Verville, V., Pallavicini, C., Sanz, C., Zamberlan, F., & Tagliazucchi, E. | Consciousness and cognition | 20 January 2019

Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study.

Stenbæk, D. S., Kristiansen, S., Burmester, D., Madsen, M. K., Frokjaer, V. G., Knudsen, G. M., & Fisher, P. M. | Human brain mapping | 11 January 2019

Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats

Sakloth, F., Leggett, E., Moerke, M. J., Townsend, E. A., Banks, M. L., & Negus, S. S. | Experimental and clinical psychopharmacology | 10 January 2019

Perceived Benefits of MDMA-Assisted Psychotherapy beyond Symptom Reduction: Qualitative Follow-Up Study of a Clinical Trial for Individuals with Treatment-Resistant PTSD.

Barone, W., Beck, J., Mitsunaga-Whitten, M., & Perl, P. | Journal of psychoactive drugs | 7 January 2019